Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Carr

Showing results (321-330 of 393) with videos related to

Pageof 40
Sort By:
Science (New York, N.Y.)|May 14, 2021
Cell-specific transcriptional control of mitochondrial metabolism by TIF1γ drives erythropoiesisMarlies P Rossmann, Karen Hoi, Victoria Chan, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Discovery of chromatin-based determinants of azacytidine and decitabine anti-cancer activityRishi V Puram, Qiangzong Yin, YuhJong Liu, et al.
Nature|February 12, 2025
UM171 glues asymmetric CRL3-HDAC1/2 assembly to degrade CoREST corepressorsMegan J R Yeo, Olivia Zhang, Xiaowen Xie, et al.
Cancer Cell|June 15, 2021
STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcomaBiniam Adane, Gabriela Alexe, Bo Kyung A Seong, et al.
Cell|July 1, 2017
Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct MechanismsVictor Rusu, Eitan Hoch, Josep M Mercader, et al.
Nature Medicine|August 15, 2017
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitorsHana Janouskova, Geniver El Tekle, Elisa Bellini, et al.
Science (New York, N.Y.)|May 8, 2025
Pancreatic cancer-restricted cryptic antigens are targets for T cell recognitionZackery A Ely, Zachary J Kulstad, Gurcan Gunaydin, et al.
Cell|March 20, 2018
Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human HematopoiesisRajiv K Khajuria, Mathias Munschauer, Jacob C Ulirsch, et al.
Nature Communications|February 3, 2021
Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancerTiziano Bernasocchi, Geniver El Tekle, Marco Bolis, et al.
Blood Cancer Discovery|January 11, 2022
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target GenesEva J Schaefer, Helen C Wang, Hannah Q Karp, et al.
Pageof 40

Showing results (321-330 of 393) with videos related to

Sort By:
Pageof 40
Science (New York, N.Y.)|May 14, 2021
Cell-specific transcriptional control of mitochondrial metabolism by TIF1γ drives erythropoiesisMarlies P Rossmann, Karen Hoi, Victoria Chan, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Discovery of chromatin-based determinants of azacytidine and decitabine anti-cancer activityRishi V Puram, Qiangzong Yin, YuhJong Liu, et al.
Nature|February 12, 2025
UM171 glues asymmetric CRL3-HDAC1/2 assembly to degrade CoREST corepressorsMegan J R Yeo, Olivia Zhang, Xiaowen Xie, et al.
Cancer Cell|June 15, 2021
STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcomaBiniam Adane, Gabriela Alexe, Bo Kyung A Seong, et al.
Cell|July 1, 2017
Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct MechanismsVictor Rusu, Eitan Hoch, Josep M Mercader, et al.
Nature Medicine|August 15, 2017
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitorsHana Janouskova, Geniver El Tekle, Elisa Bellini, et al.
Science (New York, N.Y.)|May 8, 2025
Pancreatic cancer-restricted cryptic antigens are targets for T cell recognitionZackery A Ely, Zachary J Kulstad, Gurcan Gunaydin, et al.
Cell|March 20, 2018
Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human HematopoiesisRajiv K Khajuria, Mathias Munschauer, Jacob C Ulirsch, et al.
Nature Communications|February 3, 2021
Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancerTiziano Bernasocchi, Geniver El Tekle, Marco Bolis, et al.
Blood Cancer Discovery|January 11, 2022
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target GenesEva J Schaefer, Helen C Wang, Hannah Q Karp, et al.
Pageof 40